Herpetic keratitis

Ocular Disease: Mechanisms and Management

Volumn , Issue , 2010, Pages 91-97

  Sarangi, Pranita P ^a   Rouse, Barry T ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953218842     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2983-7.00012-7     Document Type: Chapter

References (45)

1. Pepose JS, Keadle TL, Morrison LA Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol 2006, 141:547-557.
2. Pepose JS, Leib DA, Stuart PM, et al. Herpes simplex virus diseases: anterior segment of the eye. Ocular Infections and Immunity 1996, 905-932. Mosby, St. Louis. J.S. Pepose, G.N. Holland, K.R. Wilhelmus (Eds.).
3. Streilein JW, Dana MR, Ksander BR Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 1997, 18:443-449.
4. Sheridan BS, Knickelbein JE, Hendricks RL CD8 T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia. Exp Opin Biol Ther 2007, 7:1323-1331.
5. Maertzdorf J, Verjans GM, Remeijer L, et al. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis. J Infect Dis 2003, 187:550-558.
6. Deshpande S, Banerjee K, Biswas PS, et al. Herpetic eye disease: immunopathogenesis and therapeutic measures. Exp Rev Mol Med 2004, 6:1-14.
7. Biswas PS, Rouse BT Early events in HSV keratitis - setting the stage for a blinding disease. Microbes Infect 2005, 7:799-810.
8. Sarangi PP, Kim B, Kurt-Jones E, et al. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 2007, 81:11128-11138.
9. Yan XT, Tumpey TM, Kunkel SL, et al. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol Vis Sci 1998, 39:1854-1862.
10. Kim B, Tang Q, Biswas PS, et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 2004, 165:2177-2185.
11. Mercadal CM, Bouley DM, DeStephano D, et al. Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol 1993, 67:3404-3408.
12. Zhao ZS, Granucci F, Yeh L, et al. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998, 279:1344-1347.
13. Banerjee K, Deshpande S, Zheng M, et al. Herpetic stromal keratitis in the absence of viral antigen recognition. Cell Immunol 2002, 219:108-118.
14. Niemialtowski MG, Rouse BT Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 1992, 149:3035-3039.
15. Lee S, Zheng M, Kim B, et al. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 2002, 110:1105-1111.
16. Sehrawat S, Suvas S, Rouse BT, et al. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J Virol 2008, 82:6838-6851.
17. Koelle DM, Corey L Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 2003, 16:96-113.
18. Remeijer L, Doornenbal P, Geerards AJ, et al. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology 1997, 104:648-652.
19. Kwong AD, Kruper JA, Frenkel N Herpes simplex virus virion host shutoff function. J Virol 1988, 62:912-921.
20. Kurt-Jones EA, Chan M, Zhou S, et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101:1315-1320.
21. Krug A, Luker GD, Barchet W, et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103:1433-1437.
22. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317:1522-1527.
23. Aravalli RN, Hu S, Rowen TN, et al. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 2005, 175:4189-4193.
24. Cheng H, Tumpey TM, Staats HF, et al. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci 2000, 41:1402-1409.
25. Tamesis RR, Messmer EM, Rice BA, et al. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice. Eye 1994, 8:298-306.
26. Hazrati E, Galen B, Lu W, et al. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 2006, 177:8658-8666.
27. Tumpey TM, Chen SH, Oakes JE, et al. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 1996, 70:898-904.
28. Lepisto AJ, Xu M, Yagita H, et al. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis. J Leukoc Biol 2007, 81:766-774.
29. Deshpande S, Zheng M, Lee S, et al. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol 2001, 167:2902-2910.
30. Maertzdorf J, Osterhaus AD, Verjans GM IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol 2002, 169:5897-5903.
31. Yan XT, Zhuang M, Oakes JE, et al. Autocrine action of IL-10 suppresses proinflammatory mediators and inflammation in the HSV-1-infected cornea. J Leukoc Biol 2001, 69:149-157.
32. Biswas PS, Banerjee K, Kim B, et al. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J Virol 2005, 79:10589-10600.
33. Biswas PS, Banerjee K, Zheng M, et al. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J Leukoc Biol 2004, 76:868-875.
34. Rao SN Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am J Ophthalmol 2006, 141:771-772.
35. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006, 113:363-372.
36. Daheshia M, Kuklin N, Manickan E, et al. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine 1998, 16:1103-1110.
37. Tang Q, Hendricks RL Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J Exp Med 1996, 184:1435-1447.
38. Gangappa S, Manickan E, Rouse BT Control of herpetic stromal keratitis using CTLA4Ig fusion protein. Clin Immunol Immunopathol 1998, 86:88-94.
39. Seo SK, Park HY, Choi JH, et al. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J Immunol 2003, 171:576-583.
40. Sarangi PP, Kim B, Rouse BT Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis. Invest Ophthalmol Vis Sci 2008, 49:5425-5433.
41. Sehrawat S, Rouse BT Anti-inflammatory effects of FTY720 against viral induced immunopathology: role of drug induced conversion of T cells to become Foxp3+ regulators. J Immunol 2008, 180:7636-7647.
42. Long SA, Buckner JH Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells. J Autoimmun 2008, 30:293-302.
43. Benson MJ, Pino-Lagos K, Rosemblatt M, et al. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007, 204:1765-1774.
44. Tao R, de Zoeten EF, Ozkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007, 13:1299-1307.
45. Kim B, Lee S, Kaistha SD, et al. Application of FGF-2 to modulate herpetic stromal keratitis. Curr Eye Res 2006, 31:1021-1028.